FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction Cancer

https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-pembrolizumab-stomach-esophageal-her2-pdl1?cid=eb_govdel